Novavax (NVAX) Misses Q2 EPS by 4c
Get Alerts NVAX Hot Sheet
Price: $4.85 +2.97%
Revenue Growth %: +85.7%
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
SHIM, KOD, HEWA, More
Revenue Growth %: +85.7%
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
SHIM, KOD, HEWA, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q2 EPS of ($0.29), $0.04 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $8.03 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- urban-gro Inc. (UGRO) Misses Q4 EPS by 22c, offers outlook
- Cintas Corp. (CTAS) Tops Q3 EPS by 27c ; Offers Guidance
- Carnival Corp. (CCL) tops Q1 expectations as booking volumes 'hit an all-time high'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!